7Baggers

We provide you with 20 years of free, institutional-grade data for DCPH stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of DCPH. Explore the full financial landscape of DCPH stock.

Reported DateCIKTickerType
2024-05-101654151DCPH10-QUrl
2024-02-071654151DCPH10-KUrl
2023-10-301654151DCPH10-QUrl
2023-08-091654151DCPH10-QUrl
2023-05-031654151DCPH10-QUrl
2023-02-071654151DCPH10-KUrl
2022-11-031654151DCPH10-QUrl
2022-08-041654151DCPH10-QUrl
2022-05-041654151DCPH10-QUrl
2022-02-081654151DCPH10-KUrl
2021-11-021654151DCPH10-QUrl
2021-08-031654151DCPH10-QUrl
2021-05-041654151DCPH10-QUrl
2021-02-091654151DCPH10-KUrl
2020-11-051654151DCPH10-QUrl
2020-08-041654151DCPH10-QUrl
2020-05-051654151DCPH10-QUrl
2020-03-091654151DCPH10-KUrl
2019-11-041654151DCPH10-QUrl
2019-08-021654151DCPH10-QUrl
2019-05-091654151DCPH10-QUrl
2019-03-141654151DCPH10-KUrl
2018-11-081654151DCPH10-QUrl
2018-08-071654151DCPH10-QUrl
2018-06-041654151DCPHS-1Url
2018-05-081654151DCPH10-QUrl
2018-03-281654151DCPH10-KUrl
2017-11-141654151DCPH10-QUrl
2017-09-011654151DCPHS-1Url

Deciphera Pharmaceuticals, Inc
(NASDAQ:DCPH) 

DCPH stock logo

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies. Its lead drug candidate is QINLOCK used for the treatment ...

Full Time Employees: 255
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
The information provided in this report about DCPH stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.